| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncogene Proteins, Fusion | 14 | 2025 | 210 | 1.730 |
Why?
|
| Ribonuclease III | 4 | 2025 | 89 | 1.220 |
Why?
|
| DEAD-box RNA Helicases | 4 | 2025 | 121 | 1.030 |
Why?
|
| Neoplasms | 10 | 2024 | 2792 | 0.980 |
Why?
|
| Repressor Proteins | 8 | 2025 | 813 | 0.980 |
Why?
|
| Sarcoma | 7 | 2024 | 182 | 0.960 |
Why?
|
| Kidney Neoplasms | 5 | 2025 | 439 | 0.890 |
Why?
|
| Germ-Line Mutation | 7 | 2025 | 333 | 0.860 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 419 | 0.820 |
Why?
|
| Microtubule Proteins | 3 | 2009 | 27 | 0.810 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2024 | 547 | 0.800 |
Why?
|
| Receptor, trkA | 1 | 2022 | 15 | 0.780 |
Why?
|
| Mutation | 20 | 2024 | 5849 | 0.770 |
Why?
|
| Sertoli-Leydig Cell Tumor | 1 | 2022 | 16 | 0.760 |
Why?
|
| Spermatozoa | 7 | 2009 | 236 | 0.730 |
Why?
|
| DNA Copy Number Variations | 4 | 2022 | 949 | 0.720 |
Why?
|
| Soft Tissue Neoplasms | 5 | 2022 | 121 | 0.720 |
Why?
|
| High-Throughput Nucleotide Sequencing | 9 | 2024 | 880 | 0.700 |
Why?
|
| Brain Neoplasms | 5 | 2024 | 1216 | 0.700 |
Why?
|
| Biomarkers, Tumor | 12 | 2023 | 1496 | 0.670 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2022 | 72 | 0.670 |
Why?
|
| Sarcoma, Clear Cell | 2 | 2019 | 20 | 0.660 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 19 | 0.660 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 29 | 0.650 |
Why?
|
| Gene Fusion | 5 | 2024 | 55 | 0.580 |
Why?
|
| Reproduction | 2 | 2011 | 236 | 0.530 |
Why?
|
| Medulloblastoma | 1 | 2019 | 329 | 0.510 |
Why?
|
| Vulvar Neoplasms | 1 | 2016 | 18 | 0.510 |
Why?
|
| Dermatofibrosarcoma | 1 | 2016 | 17 | 0.500 |
Why?
|
| Cytoskeletal Proteins | 3 | 2022 | 271 | 0.490 |
Why?
|
| Liver Neoplasms | 5 | 2022 | 1318 | 0.480 |
Why?
|
| Colorectal Neoplasms | 2 | 2022 | 576 | 0.460 |
Why?
|
| Translocation, Genetic | 3 | 2025 | 358 | 0.460 |
Why?
|
| Neoplasm Recurrence, Local | 6 | 2023 | 1140 | 0.460 |
Why?
|
| Laboratory Proficiency Testing | 2 | 2024 | 8 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2025 | 58 | 0.450 |
Why?
|
| Germ Cells | 3 | 2024 | 195 | 0.450 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2014 | 24 | 0.440 |
Why?
|
| Infertility, Male | 6 | 2011 | 281 | 0.430 |
Why?
|
| Humans | 67 | 2025 | 125392 | 0.420 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2025 | 553 | 0.410 |
Why?
|
| Hepatoblastoma | 3 | 2022 | 179 | 0.410 |
Why?
|
| Child | 31 | 2025 | 24436 | 0.410 |
Why?
|
| Thyroid Neoplasms | 3 | 2021 | 189 | 0.400 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2022 | 934 | 0.380 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 2 | 2022 | 20 | 0.370 |
Why?
|
| Sperm Head | 2 | 2011 | 9 | 0.360 |
Why?
|
| RNA, Messenger | 2 | 2015 | 2820 | 0.360 |
Why?
|
| Genitalia, Female | 1 | 2011 | 47 | 0.350 |
Why?
|
| Sequence Analysis, RNA | 4 | 2024 | 369 | 0.350 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2017 | 1897 | 0.330 |
Why?
|
| Rhabdomyosarcoma | 2 | 2023 | 191 | 0.320 |
Why?
|
| Metabolic Diseases | 1 | 2010 | 130 | 0.310 |
Why?
|
| Pyrazoles | 2 | 2021 | 305 | 0.310 |
Why?
|
| Female | 35 | 2025 | 66885 | 0.310 |
Why?
|
| Sperm Motility | 1 | 2009 | 102 | 0.300 |
Why?
|
| Skin Neoplasms | 1 | 2016 | 862 | 0.300 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2025 | 3160 | 0.300 |
Why?
|
| Pyrimidines | 2 | 2021 | 374 | 0.300 |
Why?
|
| Male | 37 | 2025 | 61663 | 0.290 |
Why?
|
| Cyclin B | 2 | 2019 | 22 | 0.280 |
Why?
|
| Sequence Analysis, DNA | 3 | 2022 | 1756 | 0.280 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 1290 | 0.280 |
Why?
|
| Asthenozoospermia | 1 | 2007 | 6 | 0.270 |
Why?
|
| Child, Preschool | 14 | 2025 | 14030 | 0.270 |
Why?
|
| Gonads | 1 | 2007 | 35 | 0.270 |
Why?
|
| Fertility | 1 | 2009 | 259 | 0.270 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2017 | 188 | 0.260 |
Why?
|
| Sarcoma, Ewing | 2 | 2018 | 110 | 0.260 |
Why?
|
| Cell Shape | 1 | 2006 | 61 | 0.260 |
Why?
|
| beta-Galactosidase | 1 | 2006 | 147 | 0.260 |
Why?
|
| Protein C Deficiency | 1 | 2006 | 12 | 0.260 |
Why?
|
| Immunohistochemistry | 5 | 2017 | 1693 | 0.260 |
Why?
|
| Protein C | 1 | 2006 | 21 | 0.260 |
Why?
|
| Adolescent | 20 | 2025 | 19373 | 0.260 |
Why?
|
| Carcinoma | 2 | 2021 | 287 | 0.260 |
Why?
|
| Thrombophilia | 1 | 2006 | 44 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 1 | 2006 | 217 | 0.240 |
Why?
|
| Molecular Diagnostic Techniques | 2 | 2018 | 153 | 0.240 |
Why?
|
| Infant | 15 | 2025 | 12518 | 0.240 |
Why?
|
| Pineal Gland | 1 | 2025 | 18 | 0.240 |
Why?
|
| Pinealoma | 1 | 2025 | 19 | 0.240 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2025 | 22 | 0.240 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 312 | 0.230 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2025 | 39 | 0.230 |
Why?
|
| Mammals | 1 | 2006 | 258 | 0.230 |
Why?
|
| DNA Mutational Analysis | 4 | 2020 | 794 | 0.220 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 461 | 0.220 |
Why?
|
| Neoplasm Proteins | 3 | 2021 | 667 | 0.220 |
Why?
|
| Brain Abscess | 1 | 2024 | 50 | 0.220 |
Why?
|
| Models, Animal | 1 | 2006 | 464 | 0.220 |
Why?
|
| Histiocytosis, Langerhans-Cell | 2 | 2017 | 221 | 0.220 |
Why?
|
| Wilms Tumor | 1 | 2025 | 115 | 0.220 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 151 | 0.210 |
Why?
|
| Gangliosides | 1 | 2024 | 72 | 0.210 |
Why?
|
| DNA Mismatch Repair | 2 | 2022 | 50 | 0.210 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 128 | 0.210 |
Why?
|
| Meningioma | 1 | 2025 | 120 | 0.210 |
Why?
|
| Granulosa Cell Tumor | 2 | 2020 | 39 | 0.210 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 2021 | 87 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 186 | 0.210 |
Why?
|
| Genetic Testing | 4 | 2024 | 1010 | 0.200 |
Why?
|
| Circulating Tumor DNA | 1 | 2023 | 35 | 0.200 |
Why?
|
| Neutropenia | 1 | 2024 | 200 | 0.200 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2022 | 74 | 0.190 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2022 | 62 | 0.190 |
Why?
|
| Testis | 1 | 2004 | 411 | 0.190 |
Why?
|
| Maintenance Chemotherapy | 1 | 2021 | 20 | 0.190 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2021 | 8 | 0.190 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2024 | 197 | 0.190 |
Why?
|
| MyoD Protein | 1 | 2021 | 21 | 0.180 |
Why?
|
| Anticoagulants | 1 | 2006 | 594 | 0.180 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 55 | 0.180 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3746 | 0.180 |
Why?
|
| Transcription Factors | 4 | 2025 | 2593 | 0.180 |
Why?
|
| PAX7 Transcription Factor | 2 | 2018 | 17 | 0.180 |
Why?
|
| Trans-Activators | 1 | 2025 | 798 | 0.180 |
Why?
|
| RNA-Binding Protein EWS | 2 | 2018 | 33 | 0.180 |
Why?
|
| Sex Cord-Gonadal Stromal Tumors | 1 | 2020 | 10 | 0.180 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2020 | 5 | 0.180 |
Why?
|
| Astrocytoma | 1 | 2021 | 100 | 0.170 |
Why?
|
| Ovary | 2 | 2020 | 380 | 0.170 |
Why?
|
| Clonal Evolution | 1 | 2020 | 40 | 0.170 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 2048 | 0.170 |
Why?
|
| Mediastinal Neoplasms | 1 | 2020 | 43 | 0.170 |
Why?
|
| Ependymoma | 1 | 2021 | 125 | 0.170 |
Why?
|
| Carcinoma, Papillary | 1 | 2020 | 71 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2019 | 18 | 0.170 |
Why?
|
| Sarcoma, Myeloid | 1 | 2019 | 12 | 0.160 |
Why?
|
| Myofibromatosis | 1 | 2019 | 7 | 0.160 |
Why?
|
| Imatinib Mesylate | 1 | 2019 | 46 | 0.160 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 302 | 0.160 |
Why?
|
| Egg Proteins | 2 | 2011 | 55 | 0.160 |
Why?
|
| Mice | 11 | 2022 | 17637 | 0.160 |
Why?
|
| Young Adult | 10 | 2024 | 9069 | 0.160 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 15 | 0.160 |
Why?
|
| Leukemia, Myelomonocytic, Juvenile | 1 | 2019 | 9 | 0.160 |
Why?
|
| Adult | 11 | 2025 | 29692 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2020 | 158 | 0.160 |
Why?
|
| Azacitidine | 1 | 2019 | 52 | 0.160 |
Why?
|
| Testicular Neoplasms | 1 | 2020 | 132 | 0.160 |
Why?
|
| Carcinogenesis | 1 | 2022 | 333 | 0.160 |
Why?
|
| Rhabdomyosarcoma, Embryonal | 1 | 2019 | 51 | 0.150 |
Why?
|
| Oncogene Fusion | 2 | 2017 | 22 | 0.150 |
Why?
|
| Carcinoma, Small Cell | 1 | 2018 | 51 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 889 | 0.150 |
Why?
|
| Flagella | 2 | 2009 | 28 | 0.150 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 2522 | 0.150 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2019 | 183 | 0.140 |
Why?
|
| Drug Therapy | 1 | 2018 | 88 | 0.140 |
Why?
|
| Myofibroma | 1 | 2017 | 9 | 0.140 |
Why?
|
| Prognosis | 5 | 2021 | 4648 | 0.140 |
Why?
|
| Genomics | 4 | 2021 | 1499 | 0.140 |
Why?
|
| Fasciitis | 1 | 2017 | 19 | 0.140 |
Why?
|
| Algorithms | 2 | 2022 | 1630 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 135 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 314 | 0.140 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 61 | 0.140 |
Why?
|
| Animals | 12 | 2022 | 34241 | 0.140 |
Why?
|
| Data Curation | 1 | 2016 | 12 | 0.130 |
Why?
|
| Cerebellar Neoplasms | 1 | 2019 | 279 | 0.130 |
Why?
|
| Amino Acid Sequence | 5 | 2011 | 2714 | 0.130 |
Why?
|
| Genetic Variation | 3 | 2018 | 1502 | 0.130 |
Why?
|
| Databases, Genetic | 4 | 2021 | 474 | 0.130 |
Why?
|
| Neurofibroma | 1 | 2016 | 6 | 0.130 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 1711 | 0.130 |
Why?
|
| Tandem Repeat Sequences | 1 | 2015 | 37 | 0.120 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 3892 | 0.120 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2016 | 101 | 0.120 |
Why?
|
| Thyroid Nodule | 1 | 2015 | 19 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 506 | 0.120 |
Why?
|
| Immunoblotting | 1 | 2015 | 311 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 763 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2016 | 241 | 0.110 |
Why?
|
| Genome, Human | 2 | 2018 | 1273 | 0.110 |
Why?
|
| Phenotype | 3 | 2019 | 4263 | 0.110 |
Why?
|
| Leukocytosis | 1 | 2014 | 46 | 0.110 |
Why?
|
| Gene Duplication | 1 | 2015 | 362 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 468 | 0.110 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2014 | 68 | 0.110 |
Why?
|
| Karyotyping | 1 | 2014 | 323 | 0.110 |
Why?
|
| Incidental Findings | 1 | 2014 | 126 | 0.110 |
Why?
|
| Genetics, Medical | 1 | 2014 | 118 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2014 | 160 | 0.100 |
Why?
|
| Afibrinogenemia | 1 | 2012 | 10 | 0.100 |
Why?
|
| Hematologic Tests | 1 | 2012 | 35 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3583 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 426 | 0.100 |
Why?
|
| 1,4-alpha-Glucan Branching Enzyme | 1 | 2012 | 4 | 0.100 |
Why?
|
| Mononuclear Phagocyte System | 1 | 2012 | 9 | 0.100 |
Why?
|
| Glycogen Storage Disease Type IV | 1 | 2012 | 5 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2012 | 156 | 0.100 |
Why?
|
| Membrane Proteins | 2 | 2011 | 1527 | 0.100 |
Why?
|
| Meiosis | 2 | 2009 | 112 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2014 | 320 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2016 | 334 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2014 | 369 | 0.090 |
Why?
|
| Infant, Newborn | 6 | 2020 | 8240 | 0.090 |
Why?
|
| Receptor, trkB | 2 | 2021 | 20 | 0.090 |
Why?
|
| Acrosome | 2 | 2011 | 13 | 0.090 |
Why?
|
| Combined Modality Therapy | 3 | 2019 | 1244 | 0.090 |
Why?
|
| Epithelioid Cells | 1 | 2011 | 11 | 0.090 |
Why?
|
| Nuclear Envelope | 1 | 2011 | 17 | 0.090 |
Why?
|
| Computational Biology | 3 | 2018 | 810 | 0.090 |
Why?
|
| Hemochromatosis | 1 | 2011 | 33 | 0.090 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2011 | 73 | 0.090 |
Why?
|
| Abdominal Neoplasms | 1 | 2011 | 33 | 0.090 |
Why?
|
| Myofibroblasts | 1 | 2011 | 77 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2020 | 1659 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 211 | 0.080 |
Why?
|
| Retroelements | 1 | 2009 | 40 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2011 | 470 | 0.080 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2021 | 363 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2007 | 658 | 0.080 |
Why?
|
| Membrane Glycoproteins | 2 | 2021 | 411 | 0.080 |
Why?
|
| Remission Induction | 2 | 2019 | 300 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3306 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 1899 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 537 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1273 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 2022 | 614 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2009 | 699 | 0.070 |
Why?
|
| Lymphatic Metastasis | 2 | 2020 | 418 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1020 | 0.070 |
Why?
|
| Glycolipids | 1 | 2006 | 32 | 0.070 |
Why?
|
| Oligospermia | 1 | 2006 | 59 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2007 | 212 | 0.060 |
Why?
|
| Cytogenetic Analysis | 2 | 2020 | 80 | 0.060 |
Why?
|
| Contraception | 1 | 2006 | 57 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 282 | 0.060 |
Why?
|
| Ovarian Follicle | 1 | 2007 | 119 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2007 | 185 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2021 | 223 | 0.060 |
Why?
|
| Software | 2 | 2021 | 684 | 0.060 |
Why?
|
| Receptors, Purinergic P2Y | 1 | 2025 | 6 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2006 | 177 | 0.060 |
Why?
|
| Proteins | 2 | 2009 | 1036 | 0.060 |
Why?
|
| Receptors, Cytokine | 1 | 2025 | 68 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 16 | 0.060 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2024 | 20 | 0.060 |
Why?
|
| Biopsy | 2 | 2020 | 1240 | 0.060 |
Why?
|
| Forecasting | 1 | 2006 | 351 | 0.060 |
Why?
|
| Expressed Sequence Tags | 1 | 2004 | 79 | 0.060 |
Why?
|
| Precision Medicine | 2 | 2018 | 319 | 0.060 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 714 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1446 | 0.050 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1899 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2024 | 272 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 471 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2004 | 428 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 3350 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1328 | 0.050 |
Why?
|
| Biological Assay | 1 | 2023 | 104 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1251 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2022 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2022 | 53 | 0.050 |
Why?
|
| Middle Aged | 5 | 2025 | 26990 | 0.050 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2021 | 39 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2021 | 33 | 0.050 |
Why?
|
| Web Browser | 1 | 2021 | 8 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 2 | 2015 | 620 | 0.050 |
Why?
|
| Recurrence | 1 | 2025 | 1420 | 0.040 |
Why?
|
| Salpingo-oophorectomy | 1 | 2020 | 10 | 0.040 |
Why?
|
| Forkhead Box Protein L2 | 1 | 2020 | 10 | 0.040 |
Why?
|
| Quinolines | 1 | 2021 | 98 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2023 | 762 | 0.040 |
Why?
|
| Imidazoles | 1 | 2021 | 203 | 0.040 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 1691 | 0.040 |
Why?
|
| Dactinomycin | 1 | 2019 | 66 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1034 | 0.040 |
Why?
|
| Glioma | 1 | 2024 | 492 | 0.040 |
Why?
|
| Base Sequence | 1 | 2004 | 3103 | 0.040 |
Why?
|
| Foot Diseases | 1 | 2019 | 24 | 0.040 |
Why?
|
| Thoracic Neoplasms | 1 | 2019 | 38 | 0.040 |
Why?
|
| Thigh | 1 | 2019 | 51 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2019 | 74 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2018 | 1265 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 2058 | 0.040 |
Why?
|
| Thoracic Wall | 1 | 2019 | 38 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 145 | 0.040 |
Why?
|
| Extremities | 1 | 2019 | 83 | 0.040 |
Why?
|
| Hysterectomy | 1 | 2020 | 187 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2018 | 39 | 0.040 |
Why?
|
| Vincristine | 1 | 2019 | 193 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2019 | 179 | 0.040 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Genome | 1 | 2021 | 470 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 2018 | 124 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2025 | 837 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2011 | 620 | 0.040 |
Why?
|
| Codon, Nonsense | 1 | 2018 | 131 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2019 | 201 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2025 | 783 | 0.040 |
Why?
|
| Access to Information | 1 | 2018 | 40 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 101 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2024 | 832 | 0.040 |
Why?
|
| Rats | 1 | 2004 | 3727 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 417 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2018 | 212 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2018 | 231 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2019 | 244 | 0.030 |
Why?
|
| Acetylation | 1 | 2017 | 167 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2017 | 236 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2006 | 3468 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 119 | 0.030 |
Why?
|
| Everolimus | 1 | 2016 | 50 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2018 | 440 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 672 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2019 | 651 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 154 | 0.030 |
Why?
|
| Texas | 1 | 2024 | 3589 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2015 | 23 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 296 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 236 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 541 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 627 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1058 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2019 | 888 | 0.030 |
Why?
|
| Sirolimus | 1 | 2016 | 227 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 726 | 0.030 |
Why?
|
| Telomerase | 1 | 2015 | 160 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2007 | 4536 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2756 | 0.030 |
Why?
|
| beta Catenin | 1 | 2015 | 204 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 724 | 0.030 |
Why?
|
| Aged | 3 | 2017 | 19896 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2016 | 429 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 1016 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2019 | 829 | 0.030 |
Why?
|
| Histones | 1 | 2017 | 526 | 0.030 |
Why?
|
| Protein Binding | 1 | 2017 | 1756 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 7223 | 0.030 |
Why?
|
| Laboratories, Hospital | 1 | 2012 | 20 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2011 | 26 | 0.020 |
Why?
|
| Laboratories | 1 | 2012 | 81 | 0.020 |
Why?
|
| Patched-1 Receptor | 1 | 2011 | 34 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 4396 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 1699 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2018 | 691 | 0.020 |
Why?
|
| Transcriptome | 1 | 2018 | 955 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 5185 | 0.020 |
Why?
|
| Autopsy | 1 | 2011 | 113 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 175 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2011 | 128 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 359 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2176 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2011 | 211 | 0.020 |
Why?
|
| Argonaute Proteins | 1 | 2009 | 24 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2011 | 256 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2515 | 0.020 |
Why?
|
| Homozygote | 1 | 2011 | 547 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2827 | 0.020 |
Why?
|
| Zona Pellucida | 1 | 2007 | 11 | 0.020 |
Why?
|
| Fertilization | 1 | 2007 | 43 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 663 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 144 | 0.020 |
Why?
|
| Multigene Family | 1 | 2007 | 299 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2007 | 403 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2011 | 1022 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2007 | 358 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 399 | 0.010 |
Why?
|
| Liver | 1 | 2011 | 1749 | 0.010 |
Why?
|
| Swine | 1 | 2007 | 1210 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 558 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 16389 | 0.010 |
Why?
|
| United States | 1 | 2017 | 10936 | 0.010 |
Why?
|
| Mutation, Missense | 1 | 2006 | 875 | 0.010 |
Why?
|
| Gene Expression | 1 | 2006 | 1560 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10331 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 6345 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 4406 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12412 | 0.010 |
Why?
|